stockrow
Saturday 7 November 2026
Export ELV’s income statement to Excel — free account
Elevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
425.62
6.38
−1.48%
Follow ELV
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
15.55 | 15.74 | 18.50 | 16.38 | 17.93 | 18.75 | 20.26 | 19.02 | 14.40 | 13.96 |
Piotroski F-Score |
6 | 5 | 7 | 8 | 7 | 7 | 6 | 8 | 4 | 6 |
Altman Z-Score |
2.74 | 2.89 | 3.10 | 3.29 | 3.19 | 3.42 | 3.50 | 3.41 | 3.04 | 3.09 |
P/S ratio |
0.44 | 0.66 | 0.74 | 0.74 | 0.66 | 0.82 | 0.77 | 0.66 | 0.48 | 0.39 |
P/FCF ratio |
14.02 | 17.41 | 25.88 | 15.48 | 8.33 | 15.53 | 16.63 | 16.70 | 18.78 | 24.74 |
Altman Z″-Score (non-manufacturers) |
3.35 | 3.14 | 3.29 | 3.58 | 3.33 | 3.23 | 3.08 | 3.18 | 3.07 | 3.18 |
Beneish M-Score |
(2.36) | (2.43) | (2.46) | (2.36) | (2.82) | (2.33) | (2.44) | (2.48) | (2.32) | (2.26) |
P/Operating CF |
136.15 | (45.43) | 146.40 | 58.15 | 21.12 | 67.59 | (79.40) | (38.02) | 121.07 | 934.80 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 96 |
P/B ratio |
1.50 | 2.23 | 2.38 | 2.43 | 2.43 | 3.13 | 3.32 | 2.87 | 2.06 | 1.78 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 30.21 | 38.29 | 87.95 | 73.85 | 29.61 | 81.02 | 17.52 |
EV/Sales |
0.34 | 0.59 | 0.69 | 0.68 | 0.57 | 0.74 | 0.70 | 0.59 | 0.46 | 0.37 |
EV/EBITDA |
4.71 | 8.97 | 9.06 | 9.02 | 8.50 | 10.16 | 10.87 | 9.67 | 7.79 | 7.69 |
EV/Operating CF |
8.91 | 12.59 | 16.49 | 11.70 | 6.53 | 12.28 | 13.11 | 12.59 | 14.06 | 17.32 |
EV/FCF |
10.85 | 15.53 | 24.10 | 14.23 | 7.22 | 14.12 | 15.19 | 15.00 | 17.94 | 23.41 |
Quick Ratio |
1.52 | 1.45 | 1.46 | 1.53 | 1.42 | 1.33 | 1.27 | 1.30 | 1.32 | 1.41 |
Current Ratio |
1.61 | 1.55 | 1.56 | 1.66 | 1.55 | 1.47 | 1.40 | 1.44 | 1.45 | 1.54 |
Net Debt/EBITDA |
(1.38) | (1.09) | (0.67) | (0.79) | (1.30) | (1.02) | (1.03) | (1.09) | (0.36) | (0.44) |
Debt/Assets |
23.49% | 26.45% | 25.24% | 25.03% | 23.13% | 23.35% | 23.21% | 22.85% | 26.41% | 26.25% |
Debt/Equity |
0.61 | 0.70 | 0.63 | 0.61 | 0.60 | 0.63 | 0.66 | 0.63 | 0.75 | 0.72 |
Asset Turnover |
1.34 | 1.33 | 1.30 | 1.40 | 1.49 | 1.51 | 1.56 | 1.62 | 1.57 | 1.67 |
Operating CF/Net income |
1.32 | 1.09 | 1.02 | 1.26 | 2.34 | 1.36 | 1.43 | 1.35 | 0.97 | 0.76 |
Capex/Depreciation |
(0.64) | (0.89) | (1.07) | (0.95) | (0.88) | (0.83) | (0.69) | (0.74) | (0.90) | (0.72) |
Interest Coverage |
7.30 | 6.75 | 7.75 | 9.03 | 9.00 | 11.05 | 9.93 | 8.49 | 7.67 | 5.79 |
| 10.26% | 14.89% | 13.63% | 15.95% | 14.08% | 17.77% | 16.27% | 15.81% | 14.80% | 13.25% | |
| 3.90% | 5.67% | 5.28% | 6.45% | 5.57% | 6.69% | 5.89% | 5.66% | 5.30% | 4.75% | |
ROIC |
19.89% | 15.50% | 15.27% | 16.51% | 19.60% | 21.31% | 20.40% | 19.57% | 15.10% | 12.74% |
Return on Tangible Assets |
16.47% | 25.48% | 24.85% | 25.80% | 23.11% | 30.55% | 29.12% | 26.49% | 25.99% | 21.25% |
Average Days of Receivables |
36.84 | 35.65 | 36.90 | 36.39 | 32.82 | 35.38 | 37.40 | 38.06 | 39.32 | 39.49 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
14.80% | 14.05% | 15.22% | 12.82% | 14.32% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.39 | 0.39 | 0.41 | 0.38 | 0.36 | 0.36 | 0.34 | 0.33 | 0.35 | 0.33 |
Share Based Compensation of Revenue |
0.19% | 0.19% | 0.25% | 0.28% | 0.23% | 0.18% | 0.17% | 0.17% | 0.11% | 0.14% |
Graham Net Nets |
(0.15) | (0.13) | (0.13) | (0.09) | (0.10) | (0.09) | (0.09) | (0.08) | (0.19) | (0.18) |
Graham Number |
140.66 | 180.96 | 187.96 | 226.99 | 230.96 | 287.09 | 290.57 | 307.57 | 320.97 | 333.30 |
Earnings Yield |
6.43% | 6.35% | 5.41% | 6.11% | 5.58% | 5.33% | 4.94% | 5.26% | 6.94% | 7.17% |
Free Cash Flow Yield |
7.13% | 5.74% | 3.86% | 6.46% | 12.00% | 6.44% | 6.01% | 5.99% | 5.33% | 4.04% |
Revenue per Share |
322.80 | 344.32 | 356.86 | 407.88 | 485.91 | 568.66 | 652.48 | 726.32 | 763.97 | 888.95 |
Operating CF per Share |
12.44 | 16.00 | 14.83 | 23.72 | 42.62 | 34.31 | 35.00 | 34.17 | 25.07 | 19.15 |
Capex per Share |
(2.22) | (3.02) | (4.68) | (4.22) | (4.07) | (4.46) | (4.80) | (5.49) | (5.42) | (4.98) |
Free Cash Flow per Share |
10.22 | 12.98 | 10.15 | 19.51 | 38.54 | 29.85 | 30.20 | 28.68 | 19.65 | 14.17 |
Cash per Share |
90.54 | 95.82 | 88.12 | 100.28 | 122.54 | 135.47 | 142.88 | 154.17 | 149.68 | 161.23 |
Shareholders Equity per Share |
95.48 | 101.35 | 110.58 | 124.18 | 132.37 | 148.19 | 151.38 | 167.04 | 178.79 | 196.54 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
95.48 | 101.35 | 110.58 | 124.18 | 132.37 | 148.19 | 151.38 | 167.04 | 178.79 | 196.54 |
Free Cash Flow |
2,686.00 | 3,394.00 | 2,619.00 | 4,984.00 | 9,667.00 | 7,277.00 | 7,247.00 | 6,765.00 | 4,552.00 | 3,174.00 |
Working Capital |
13,020.50 | 12,907.00 | 12,356.00 | 15,501.00 | 16,298.00 | 16,237.00 | 15,921.00 | 18,238.00 | 18,361.00 | 21,966.00 |
Capital Expenditures |
(584.00) | (791.00) | (1,208.00) | (1,077.00) | (1,021.00) | (1,087.00) | (1,152.00) | (1,296.00) | (1,256.00) | (1,116.00) |
Net Current Asset Value |
(5,667.80) | (7,774.00) | (8,709.00) | (6,692.00) | (7,665.00) | (10,210.00) | (10,808.00) | (9,494.00) | (16,521.00) | (14,467.00) |
EV/EBIT |
5.52 | 10.57 | 10.82 | 10.53 | 9.89 | 11.66 | 13.03 | 11.60 | 8.98 | 9.16 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
7.13 | 11.86 | 11.62 | 11.46 | 11.41 | 12.82 | 14.26 | 12.92 | 9.40 | 9.68 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.46 | 0.41 | 0.41 | 0.36 | 0.33 | 0.33 | 0.39 | 0.40 | 0.30 | 0.33 |
Cash ROIC |
4.18% | 4.83% | 3.78% | 6.50% | 11.51% | 7.92% | 7.67% | 6.72% | 4.26% | 2.83% |
Accounts Receivable Turnover |
10.67 | 10.37 | 10.17 | 10.58 | 11.42 | 11.36 | 10.62 | 10.11 | 9.58 | 9.81 |
Accounts Payable Turnover |
5.78 | 5.72 | 5.56 | 6.51 | 6.49 | 6.42 | 6.53 | 6.40 | 6.45 | 7.20 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
65.93 | 66.69 | 64.40 | 56.81 | 63.41 | 59.47 | 59.68 | 59.33 | 56.18 | 52.59 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
7,953.45 | 8,680.05 | 9,052.50 | 9,851.00 | 10,674.50 | 12,199.00 | 14,742.00 | 16,954.50 | 18,468.00 | 20,306.50 |
Average Payables |
11,553.20 | 12,635.90 | 12,942.00 | 12,862.50 | 14,946.00 | 17,670.00 | 19,845.50 | 22,112.00 | 22,847.00 | 23,539.50 |
Average Assets |
63,400.45 | 67,811.55 | 71,055.50 | 74,512.00 | 82,034.00 | 92,037.50 | 100,107.50 | 105,841.50 | 112,908.50 | 119,191.50 |
Average Common Equity |
24,072.25 | 25,801.70 | 27,522.00 | 30,134.50 | 32,463.50 | 34,663.50 | 36,229.00 | 37,867.50 | 40,415.50 | 42,726.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026